SAN DIEGO, March 28, 2024 /PRNewswire/ Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate.
Amwell®, a leader in digital healthcare enablement, today announced participation in the following investor conferences and events:
On Nov. 8 2023, Roy Schoenberg, M.D., MPH, Amwell’s CEO and.